Summary Serum levels of alpha1-antitrypsin (alAT) were measured by radial immunodiffusion and phenotypes were determined by electrofocusing in acrylamide gel in 39 patients with hepatocellular carcinoma (HCC) positive for serum hepatitis B surface antigen (HBsAg), 41 patients with HCC negative for serum HBsAg, and 160 age-and sex-matched hospital controls. There was no difference between the control series and either of the two HCC groups with respect to a,AT phenotype pattern; also, there was no evidence of association between HCC and either the M2 allele or any of the alAT deficiency phenotypes. However, HCC cases negative for HBsAg had significantly higher serum cx1AT values (mean 665 + 26mg 100ml-1) than HCC cases positive for HBsAg (mean 571+23mg lOOml-1), who in turn, had significantly higher alAT values than hospital controls (mean 434+13mg 100 ml 1). These results indicate that (i) in Greece, as in other high HCC incidence countries, genetically determined alAT deficiency is not aetiologically important; (ii) the increase of serum c,AT is an important correlate of HCC with possible aetiologic significance and diagnostic potential and (iii) HBsAg-positive HCC and HBsAg-negative HCC are manifest differently as well as being aetiologically distinct.
Alpha1-antitrypsin (a]AT) is one of nine distinct plasma proteins which have been characterized as protease inhibitors (Harpel, 1983) ; it is a glycoprotein synthesized in the liver and it is responsible for about 90 per cent of the tryptic inhibitory capacity of human serum (Sharp, 1976; Kew et al., 1978; Morse, 1978; Chio & Oon, 1979) . i1AT is under genetic control, and more than 30 codominant alleles at a single chromosomal locus have been identified (Chapuis-Cellier, 1975; Cox, 1978; Morse, 1978) . Some of these alleles (particularly the alleles Z, I, S, and perhaps P and other less common ones) have been associated with serum cz1AT deficiency of varying degree (ChapuisCellier, 1975; Morse, 1978; Chapuis-Cellier & Arnaud, 1979) and with the presence in the liver of periodic acid-Schiff(PAS)-positive, diastase-resistant globules (Sharp, 1976; Morse, 1978; Palmer et al., 1980 ). There appears to be an intriguing link between a1AT and hepatocellular carcinoma (HCC) but the evidence is not clear cut (Sharp, 1976; Kew et al., 1978; Morse, 1978; Kelly et al., 1979) . We have studied the association between e1AT and HCC in a large group of HCC cases and matched controls, using adequate laboratory procedures "blindly" (with respect to disease status), in a European population with an unusually high incidence of HCC (Trichopoulos et al., 1982) .
Patients and methods
Two hundred and forty patients were studied; they were Caucasians, of Greek nationality and residence, hospitalized in one of eight large hospitals of Athens during a 15-month period in 1976 and 1977. Among them 80 had HCC (confirmed histologically in 47 cases and by diagnostic alpha-fetoprotein (aFP) values in the remaining 33 cases); for each of them two control patients, matched for age and sex, were selected from the same hospitals with diagnoses other than neoplasm or liver disease. Among HCC patients ("cases") 69 (86%) were males and the average age was 63 years; among comparison patients ("controls") the corresponding figures were 138 males (86%) and 62 years. All patients were interviewed, and blood samples were taken from each.
Hepatitis B serologic markers were determined in all of the sera by radioimmunoassay; samples of 39 cases (49%) and 12 controls (8%) were found to be positive for hepatitis B surface antigen (HBsAg) and were considered to have chronic infection. The two HCC groups (HBsAg positive and HBsAg negative) were of similar age and sex (mean age, 63 years in both series; proportion of males 85% and 88% respectively). Therefore, age and sex adjustments were not necessary for comparisons between controls and either or both of the two HCC groups (Trichopoulos et al., 1978) .
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electrofocusing in acrylamide gel, respectively (Vesterberg, 1973; Chapuis-Cellier, 1975 could reflect a specific association between a,AT and tobacco-related HBsAg-negative HCC. There is some evidence in the present data that this may be so, but it is far from conclusive. Among patients with HBsAg-negative HCC, markedly elevated concentrations of serum x1AT (>600mg 100mlt1) were found in 21/31 current smokers (68%) but only in 5/10 non-smokers (50%); however, the difference is neither statistically significant nor dose-dependent (Table III) . We have also investigated whether, among HCC patients, there is a positive correlation between the serum concentrations of aFP (after logtransformation) and a1AT. There is no such evidence in the present data; among HBsAgpositive HCC patients the correlation coefficient is + 0.04, whereas among HBsAg-negative HCC patients the corresponding value is +0.05.
Discussion
The association between alAT and HCC has been studied from several points of view. Individuals who are homozygous for the Z allele (and perhaps other alleles associated with a1AT deficiency) have an increased risk for HCC, and many of them have the characteristic globular bodies in their livers. However, it is not clear whether individuals who B are heterozygous for these alleles are at increased risk for HCC; many studies have noted modest associations but several others have not, even though heterozygotes have consistently the same characteristic globules in their livers (studies reviewed by Sharp, 1976; Kew et al., 1978; Morse, 1978; Kelly et al., 1979; Sizaret et al., 1981; Spech & Liehr, 1982 Kew et al., (1978) , Chio & Oon (1979), and Matsuzaki et al. (1981) . Our findings confirm the results of the earlier investigations and indicate that the elevation is sufficiently marked to be aetiologically intriguing and diagnostically useful. Furthermore, we have found that serum a1AT values are, on the average, higher in HBsAgnegative cases of HCC than in HBsAg-positive cases of this tumour-an observation not reported previously. Although the difference is not sufficiently large to be of clinical importance it suggests that the aetiologic heterogeneity of HCC is reflected not only in the epidemiologic parameters but also in the laboratory findings of the aetiologic subgroups.
The molecular, biochemical and histological aspects of the association between aeAT and HCC have been reviewed elsewhere (Sharp, 1976; Morse, 1978; Palmer et al., 1980; Spech & Liehr, 1982) . However, the differential increase of acAT in HBsAg-positive and HBsAg-negative HCC, if real, calls for explanation. Several possibilities exist. Tobacco smoking has been found to increase the serum levels of alAT by -20% (Lellouch et al., 1979 ) and this proportional excess may also concern the tobacco related HCC cases. It should be noted, also, that cirrhosis is associated with reduced levels of serum alAT (Chio & Oon, 1979; Matsuzaki et al., 1981) , and cirrhosis (in Greece, at least) is more frequently associated with HBsAgpositive than with HBsAg-negative HCC (Trichopoulos et al., 1982) . Palmer et al. (1980) , using ultrastructural, histochemical and immunocytochemical methods have demonstrated the occasional parallel emergence of aFP and acAT as tumour tissue markers in malignant hepatoma (HCC). It is, therefore, surprising that a significant positive association was not evident between the serum values of aFP and a1AT in the present study or in the earlier study of Chio & Oon (1979) . Although chance is a likely explanation for the absence of a significant association, it is also possible that the epigenetic emergence of ajAT as tumour tissue marker is not frequently accompanied by an increase in the serum levels of ciAT (Palmer et al., 1980) . Supported by a grant from the Greek Ministry of Health.
